Risk Factors for Drug-resistant Streptococcus pneumoniae and Antibiotic Prescribing Practices in Outpatient Community-acquired Pneumonia

被引:32
|
作者
Jenkins, Timothy C. [1 ,2 ,6 ,7 ]
Sakai, Joy [6 ]
Knepper, Bryan C. [3 ]
Swartwood, Claire J. [4 ,8 ]
Haukoos, Jason S. [5 ,9 ,10 ]
Long, Jeremy A. [1 ,6 ]
Price, Connie S. [1 ,2 ,6 ,7 ]
Burman, William J. [1 ,2 ,6 ,7 ]
机构
[1] Denver Hlth Med Ctr, Dept Med, Denver, CO USA
[2] Denver Hlth Med Ctr, Div Infect Dis, Denver, CO USA
[3] Denver Hlth Med Ctr, Dept Patient Safety & Qual, Denver, CO USA
[4] Denver Hlth Med Ctr, Dept Pharm, Denver, CO USA
[5] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA
[6] Univ Colorado Denver, Dept Med, Aurora, CO USA
[7] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA
[8] Univ Colorado Denver, Dept Pharm, Aurora, CO USA
[9] Univ Colorado Denver, Dept Emergency Med, Aurora, CO USA
[10] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA
关键词
ANTIMICROBIAL RESISTANCE; FLUOROQUINOLONES; EMERGENCE;
D O I
10.1111/j.1553-2712.2012.01365.x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Due to antimicrobial resistance in Streptococcus pneumoniae, national guidelines recommend a respiratory fluoroquinolone or combination antimicrobial therapy for outpatient treatment of community-acquired pneumonia (CAP) associated with risk factors for drug-resistant S. pneumoniae (DRSP). The objectives of this study were to assess the prevalence of these risk factors and antibiotic prescribing practices in cases of outpatient CAP treated in the acute care setting. Methods: This was a retrospective cohort study of adult outpatients treated for CAP in the emergency department (ED) or urgent care center of an urban, academic medical center from May 1, 2009, through October 31, 2009, and comparison of antibiotic therapy in cases with and without DRSP risk factors. Results: Of 175 patients, 90 (51%) had at least one DRSP risk factor, most commonly asthma (n = 28, 16%), alcohol abuse (n = 24, 14%), diabetes mellitus (n = 18, 10%), chronic obstructive pulmonary disease (n = 16, 9%), age > 65 years (n = 16, 9%), and use of antibiotics within 3 months (15, 9%). Antibiotic prescriptions were similar among cases with and without DRSP risk factors: a macrolide (62% vs. 59%, respectively, p = 0.65), doxycycline (27% vs. 28%, p = 0.82), or a respiratory fluoroquinolone (9% vs. 9%, p = 0.90). Concordance with national guideline treatment recommendations was significantly lower in cases with DRSP risk factors (9% vs. 87%, p < 0.0001). Conclusions: DRSP risk factors were present in approximately half of outpatient CAP cases treated in the acute care setting; however, guideline-concordant antibiotic therapy was infrequent. Strict adherence to current guidelines would substantially increase use of fluoroquinolones or combination therapy. Whether the potential risks associated with these broad-spectrum regimens are justified by improved clinical outcomes requires further study. ACADEMIC EMERGENCY MEDICINE 2012; 19: 703-706 (C) 2012 by the Society for Academic Emergency Medicine
引用
收藏
页码:703 / 706
页数:4
相关论文
共 50 条
  • [1] Drug-resistant Streptococcus pneumoniae in community-acquired pneumonia
    Michael Henry
    Howard L. Leaf
    Current Infectious Disease Reports, 2003, 5 (3) : 230 - 237
  • [2] Risk Factors For Drug-Resistant Community-Acquired Pneumonia
    Sayiner, A.
    Erbey, H.
    Kaptan, Y.
    Aydemir, S.
    Tunger, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Prevalence And Risk Factors Of Drug-Resistant Streptococcus Pneumoniae In Patients With Community-Acquired Pneumonia: A Multinational Point Prevalence Study
    Reyes, L. F.
    Cook, G. S.
    Aliberti, S.
    Rodriguez, A. H.
    Sanz Herrero, F.
    Anzueto, A.
    Restrepo, M. I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [4] Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae
    Ewig, S
    Ruiz, M
    Torres, A
    Marco, F
    Martinez, JA
    Sanchez, M
    Mensa, J
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) : 1835 - 1842
  • [5] Moxifloxacin in the treatment of community-acquired pneumonia associated with drug-resistant Streptococcus pneumoniae.
    Fogarty, C
    Choudhri, S
    Herrington, J
    Painter, B
    Perroncel, R
    Church, D
    PHARMACOTHERAPY, 2002, 22 (10): : 1351 - 1351
  • [6] Community-Acquired Pneumonia with Risk for Drug-Resistant Pathogens
    Fleming, Virginia
    Buck, Brian
    Nix, Nancy
    Kumar, Parag
    Southwood, Robin
    SOUTHERN MEDICAL JOURNAL, 2013, 106 (03) : 209 - 216
  • [7] Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in an Era of Drug-Resistant Streptococcus pneumoniae
    Pablo Bonvehi
    Katherine Weber
    Todd Busman
    Dee Shortridge
    Gerard Notario
    Clinical Drug Investigation, 2003, 23 : 491 - 501
  • [8] Comparison of clarithromycin and amoxicillin/clavulanic acid for community-acquired pneumonia in an era of drug-resistant Streptococcus pneumoniae
    Bonvehi, P
    Weber, K
    Busman, T
    Shortridge, D
    Notario, G
    CLINICAL DRUG INVESTIGATION, 2003, 23 (08) : 491 - 501
  • [9] Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia
    Shindo, Yuichiro
    Ito, Ryota
    Kobayashi, Daisuke
    Ando, Masahiko
    Ichikawa, Motoshi
    Shiraki, Akira
    Goto, Yasuhiro
    Fukui, Yasutaka
    Iwaki, Mai
    Okumura, Junya
    Yamaguchi, Ikuo
    Yagi, Tetsuya
    Tanikawa, Yoshimasa
    Sugino, Yasuteru
    Shindoh, Joe
    Ogasawara, Tomohiko
    Nomura, Fumio
    Saka, Hideo
    Yamamoto, Masashi
    Taniguchi, Hiroyuki
    Suzuki, Ryujiro
    Saito, Hiroshi
    Kawamura, Takashi
    Hasegawa, Yoshinori
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (08) : 985 - 995
  • [10] Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care
    Saatchi, Ariana
    Haverkate, Manon R.
    Reid, Jennifer N.
    Shariff, Salimah Z.
    Povitz, Marcus
    Patrick, David M.
    Silverman, Michael
    Morris, Andrew M.
    Mccormack, James
    Marra, Fawziah
    BMC PEDIATRICS, 2023, 23 (01)